Financial Assets and Liabilities (Tables)

3 Months Ended

Jan. 31, 2021

Financial Assets And Liabilities [Abstract]

Summary of Cash Equivalents

As of January 31, 2021, the balances of the Company’s cash equivalents were:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses Less Than 12 Continuous Months		Gross Unrealized Losses 12 Continuous Months or Longer		Estimated Fair Value(1)
	(in thousands)
Cash equivalents:
Money market funds	$	166,882	$	—	$	—	$	—	$	166,882
Total:	$	166,882	$	—	$	—	$	—	$	166,882

(1)See Note 7. Fair Value Measures for further discussion on fair values of cash equivalents.

As of October 31, 2020, the balances of the Company’s cash equivalents were:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses Less Than 12 Continuous Months		Gross Unrealized Losses 12 Continuous Months or Longer		Estimated Fair Value(1)
	(in thousands)
Cash equivalents:
Money market funds	$	304,127	$	—	$	—	$	—	$	304,127
Total:	$	304,127	$	—	$	—	$	—	$	304,127

(1)See Note 7. Fair Value Measures for further discussion on fair values of cash equivalents.

Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the unaudited condensed consolidated balance sheets:

	As of
	January 31, 2021		October 31, 2020
	(in thousands)
Cash and cash equivalents	$	1,023,074	$	1,235,653
Restricted cash included in Prepaid expenses and other current assets	1,523		1,523
Restricted cash included in Other long-term assets	808		794
Total cash, cash equivalents and restricted cash	$	1,025,405	$	1,237,970

Effects on Changes in Fair Values of Non-Designated Forward Contracts

The effects of the non-designated derivative instruments on the Company’s unaudited condensed consolidated statements of operations is summarized as follows:

	Three Months Ended   January 31,
	2021		2020
	(in thousands)
Gain (loss) recorded in other income (expense), net	$	1,129	$	245

Notional Amounts of Derivative Instruments

The notional amounts in the table below for derivative instruments provide one measure of the transaction volume outstanding:

	As of
	January 31, 2021		October 31, 2020
	(in thousands)
Total gross notional amount	$	865,642	$	981,234
Net fair value	$	6,047	$	6,940

Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet

The following table represents the unaudited condensed consolidated balance sheets location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:

	Fair values of derivative instruments designated as hedging instruments		Fair values of derivative instruments not designated as hedging instruments
	(in thousands)
Balance at January 31, 2021
Other current assets	$	9,870	$	23
Accrued liabilities	$	3,384	$	463
Balance at October 31, 2020
Other current assets	$	9,182	$	138
Accrued liabilities	$	2,088	$	292

Income Statement Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax

The following table represents the unaudited condensed consolidated statements of operations location in Revenue/Deferred Revenue and Operating Expenses and amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax:

	Location of gain (loss) recognized in OCI on derivatives	Amount of gain (loss) recognized in OCI on derivatives (effective portion)		Location of gain (loss) reclassified from OCI	Amount of gain (loss) reclassified from OCI (effective portion)
	(in thousands)
Three months ended   January 31, 2021
Foreign exchange contracts	Revenue	$	(163)	Revenue	$	113
Foreign exchange contracts	Operating expenses	4,256		Operating expenses	2,613
Total		$	4,093		$	2,726
Three months ended   January 31, 2020
Foreign exchange contracts	Revenue	$	1,080	Revenue	$	(89)
Foreign exchange contracts	Operating expenses	571		Operating expenses	(433)
Total		$	1,651		$	(522)